How mice are indispensable for understanding obesity and diabetes genetics

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 24, Issue 2, 2017, Pages 83-91

  Attie, Alan D ^a   Churchill, Gary A ^b   Nadeau, Joseph H ^c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b JACKSON LABORATORY   (United States)

^c PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

Author keywords

Diabetes; Metabolic disease; Mouse genetics; Obesity; Systems biology

Indexed keywords

AGOUTI PROTEIN; LEPTIN;

BREEDING; CHEMICAL MUTAGENESIS; CHROMOSOME SUBSTITUTION STRAIN; COLLABORATIVE CROSS; DIABETES MELLITUS; EPIGENETICS; EPISTASIS; EVOLUTIONARY HOMOLOGY; GENE EDITING; GENE INTERACTION; GENE MUTATION; GENETIC RESOURCE; GENETIC SCREENING; GENETIC TRAIT; GENETIC VARIABILITY; GENETIC VARIATION; GENETICALLY ENGINEERED MOUSE STRAIN; GENETICS; GENOMICS; HUMAN; HYBRID MOUSE STRAIN; MICROBIOME; MODIFIER GENE; MOUSE; MOUSE MODEL; MOUSE STRAIN; NONHUMAN; OBESITY; PHENOTYPIC VARIATION; PLEIOTROPY; RECOMBINANT INBRED STRAIN; REVIEW; ANIMAL; MEDICAL RESEARCH; PHENOTYPE; PROCEDURES; TRANSGENIC MOUSE;

ANIMALS; BIOMEDICAL RESEARCH; DIABETES MELLITUS; GENETIC TESTING; GENETIC VARIATION; HUMANS; MICE; MICE, TRANSGENIC; OBESITY; PHENOTYPE;

EID: 85009973169     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0000000000000321     Document Type: Review

References (79)

1. Argmann CA, Houten SM, Zhu J, Schadt EE. A next generation multiscale view of inborn errors of metabolism. Cell Metab 2016; 23:13-26.
2. Williams EG, Auwerx J. The convergence of systems and reductionist approaches in complex trait analysis. Cell 2015; 162:23-32.
3. International HapMap. Altshuler DM, Gibbs RA, Peltonen L, et al. Integrating common and rare genetic variation in diverse human populations. Nature 2010; 467:52-58.
4. Lek M, Karczewski KJ, Minikel EV, et al., Exome Aggregation Consortium. Analysis of protein-coding genetic variation in 60 706 humans. Nature 2016; 536:285-291.
5. Fuchsberger C, Flannick J, Teslovich TM, et al. The genetic architecture of type 2 diabetes. Nature 2016; 536:41-47.
6. Paigen K. One hundred years of mouse genetics: an intellectual history. II. The molecular revolution (1981-2002). Genetics 2003; 163:1227-1235.
7. Wang X, Pandey AK, Mulligan MK, et al. Joint mouse-human phenome-wide association to test gene function and disease risk. Nat Commun 2016; 7:10464.
8. Harms DW, Quadros RM, Seruggia D, et al. Mouse genome editing using the CRISPR/Cas system. Curr Protoc Hum Genet 2014; 83:11-27.
9. Dickinson ME, Flenniken AM, Ji X, et al. High-throughput discovery of novel developmental phenotypes. Nature 2016; 537:508-514.
10. Hrabe de Angelis M, Nicholson G, Selloum M, et al. Analysis of mammalian gene function through broad-based phenotypic screens across a consortium of mouse clinics. Nat Genet 2015; 47:969-978.
11. White JK, Gerdin AK, Karp NA, et al. Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes. Cell 2013; 154:452-464.
12. Ingalls AM, Dickie MM, Snell GD. Obese, a new mutation in the house mouse. J Hered 1950; 41:317-318.
13. Hummel KP, Dickie MM, Coleman DL. Diabetes, a new mutation in the mouse. Science 1966; 153:1127-1128.
14. Coleman DL, Hummel KP. Hyperinsulinemia in preweaning diabetes (db) mice. Diabetologia 1974; 10:607-610.
15. Coleman DL. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 1973; 9:294-298.
16. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372:425-432.
17. Tartaglia LA, Dembski M, Weng X, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995; 83:1263-1271.
18. El Ouaamari A, Kawamori D, Dirice E, et al. Liver-derived systemic factors drive beta cell hyperplasia in insulin-resistant states. Cell Rep 2013; 3:401-410.
19. El Ouaamari A, Dirice E, Gedeon N, et al. SerpinB1 promotes pancreatic b cell proliferation. Cell Metab 2016; 23:194-205.
20. Stern JH, Rutkowski JM, Scherer PE. Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk. Cell Metab 2016; 23:770-784.
21. Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 con-tributes to insulin resistance in obesity and type 2 diabetes. Nature 2005; 436:356-362.
22. Schwartz DR, Lazar MA. Human resistin: found in translation from mouse to man. Trends Endocrinol Metab 2011; 22:259-265.
23. Lu D, Willard D, Patel IR, et al. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 1994; 371:799-802.
24. Loos RJ, Lindgren CM, Li S, et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 2008; 40:768-775.
25. Bhatnagar S, Oler AT, Rabaglia ME, et al. Positional cloning of a type 2 diabetes quantitative trait locus; tomosyn-2, a negative regulator of insulin secretion. PLoS Genet 2011; 7:e1002323.
26. Kebede MA, Oler AT, Gregg T, et al. SORCS1 is necessary for normal insulin secretory granule biogenesis in metabolically stressed beta cells. J Clin Invest 2014; 124:4240-4256.
27. Kluth O, Matzke D, Kamitz A, et al. Identification of four mouse diabetes candidate genes altering beta-cell proliferation. PLoS Genet 2015; 11:e1005506.
28. Scherneck S, Nestler M, Vogel H, et al. Positional cloning of zinc finger domain transcription factor Zfp69, a candidate gene for obesity-associated diabetes contributed by mouse locus Nidd/SJL. PLoS Genet 2009; 5:e1000541.
29. Darvasi A. Interval-specific congenic strains (ISCS): an experimental design for mapping a QTL into a 1-centimorgan interval. Mamm Genome 1997; 8:163-167.
30. Buchner DA, Nadeau JH. Contrasting genetic architectures in different mouse reference populations used for studying complex traits. Genome Res 2015; 25:775-791.
31. Coleman DL, Hummel KP. The influence of genetic background on the expression of the obese (Ob) gene in the mouse. Diabetologia 1973; 9:287-293.
32. Nadeau JH. Modifier genes in mice and humans. Nat Rev Genet 2001; 2:165-174.
33. Keller MP, Choi Y, Wang P, et al. A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility. Genome research 2008; 18:706-716.
34. Shao H, Burrage LC, Sinasac DS, et al. Genetic architecture of complex traits: large phenotypic effects and pervasive epistasis. Proc Natl Acad Sci USA 2008; 105:19910-19914.
35. Heard E, Martienssen RA. Transgenerational epigenetic inheritance: myths and mechanisms. Cell 2014; 157:95-109.
36. Rando OJ. Intergenerational Transfer of Epigenetic Information in Sperm. Cold Spring Harb Perspect Med 2016; 6:6.
37. Schaefer S, Nadeau JH. The genetics of epigenetic inheritance: modes, molecules, and mechanisms. Q Rev Biol 2015; 90:381-415.
38. Cropley JE, Eaton SA, Aiken A, et al. Male-lineage transmission of an acquired metabolic phenotype induced by grand-paternal obesity. Mol Metab 2016; 5:699-708.
39. de Castro Barbosa T, Ingerslev LR, Alm PS, et al. High-fat diet reprograms the epigenome of rat spermatozoa and transgenerationally affects metabolism of the offspring. Mol Metab 2016; 5:184-197.
40. Grandjean V, Fourre S, De Abreu DA, et al. RNA-mediated paternal heredity of diet-induced obesity and metabolic disorders. Sci Rep 2015; 5:18193.
41. Huypens P, Sass S, Wu M, et al. Epigenetic germline inheritance of diet-induced obesity and insulin resistance. Nat Genet 2016; 48:497-499.
42. Jimenez-Chillaron JC, Isganaitis E, Charalambous M, et al. Intergenerational transmission of glucose intolerance and obesity by in utero undernutrition in mice. Diabetes 2009; 58:460-468.
43. Wei Y, Yang CR, Wei YP, et al. Paternally induced transgenerational inheritance of susceptibility to diabetes in mammals. Proc Natl Acad Sci USA 2014; 111:1873-1878.
44. Carone BR, Fauquier L, Habib N, et al. Paternally induced transgenerational environmental reprogramming of metabolic gene expression in mammals. Cell 2010; 143:1084-1096.
45. Krautkramer KA, Kreznar JH, Romano KA, et al. Diet-microbiota interactions mediate global epigenetic programming in multiple host tissues. Mol Cell 2016; 64:982-992.
46. Yazbek SN, Spiezio SH, Nadeau JH, Buchner DA. Ancestral paternal geno-type controls body weight and food intake for multiple generations. Hum Mol Genet 2010; 19:4134-4144.
47. Pedersen HK, Gudmundsdottir V, Nielsen HB, et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 2016; 535:376-381.
48. Backhed F. Programming of host metabolism by the gut microbiota. Ann Nutr Metab 2011; 58 (Suppl 2):44-52.
49. Benson AK, Kelly SA, Legge R, et al. Individuality in gut microbiota com-position is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc Natl Acad Sci USA 2010; 107:18933-18938.
50. Fujisaka S, Ussar S, Clish C, et al. Antibiotic effects on gut microbiota and metabolism are host dependent. J Clin Invest 2016; 126:4430-4443.
51. McKnite AM, Perez-Munoz ME, Lu L, et al. Murine gut microbiota is defined by host genetics and modulates variation of metabolic traits. PLoS One 2012; 7:e39191.
52. Ussar S, Fujisaka S, Kahn CR. Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome. Mol Metab 2016; 5:795-803.
53. Ussar S, Griffin NW, Bezy O, et al. Interactions between gut microbiota, host genetics and diet modulate the predisposition to obesity and metabolic syndrome. Cell Metab 2015; 22:516-530.
54. Churchill GA, Airey DC, Allayee H, et al. The collaborative cross, a community resource for the genetic analysis of complex traits. Nature genetics 2004; 36:1133-1137.
55. Abu-Toamih Atamni HJ, Ziner Y, Mott R, et al. Glucose tolerance female-specific QTL mapped in collaborative cross mice. Mamm Genome 2016.
56. Atamni HJ, Botzman M, Mott R, et al. Mapping liver fat female-dependent quantitative trait loci in collaborative cross mice. Mamm Genome 2016; 27:565-573.
57. Nachshon A, Abu-Toamih Atamni HJ, Steuerman Y, et al. Dissecting the effect of genetic variation on the hepatic expression of drug disposition genes across the collaborative cross mouse strains. Front Genet 2016; 7:172.
58. Chesler EJ, Gatti DM, Morgan AP, et al. Diversity outbred mice at 21: maintaining allelic variation in the face of selection. G3 (Bethesda) 2016; 6:3893-3902.
59. Chick JM, Munger SC, Simecek P, et al. Defining the consequences of genetic variation on a proteome-wide scale. Nature 2016; 534:500-505.
60. Andreux PA, Williams EG, Koutnikova H, et al. Systems genetics of metabolism: the use of the BXD murine reference panel for multiscalar integration of traits. Cell 2012; 150:1287-1299.
61. Williams EG, Wu Y, Jha P, et al. Systems proteomics of liver mitochondria function. Science 2016; 352:aad0189.
62. Wu Y, Williams EG, Dubuis S, et al. Multilayered genetic and omics dissection of mitochondrial activity in a mouse reference population. Cell 2014; 158:1415-1430.
63. Lusis AJ, Seldin MM, Allayee H, et al. The hybrid mouse diversity panel: a resource for systems genetics analyses of metabolic and cardiovascular traits. J Lipid Res 2016; 57:925-942.
64. Bennett BJ, Davis RC, Civelek M, et al. Genetic architecture of atherosclerosis in mice: a systems genetics analysis of common inbred strains. PLoS Genet 2015; 11:e1005711.
65. Parks BW, Nam E, Org E, et al. Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. Cell Metab 2013; 17:141-152.
66. Parks BW, Sallam T, Mehrabian M, et al. Genetic architecture of insulin resistance in the mouse. Cell Metab 2015; 21:334-346.
67. Hui ST, Parks BW, Org E, et al. The genetic architecture of NAFLD among inbred strains of mice. Elife 2015; 4:e05607.
68. Singer JB, Hill AE, Burrage LC, et al. Genetic dissection of complex traits with chromosome substitution strains of mice. Science 2004; 304:445-448.
69. Sinasac DS, Riordan JD, Spiezio SH, et al. Genetic control of obesity, glucose homeostasis, dyslipidemia and fatty liver in a mouse model of diet-induced metabolic syndrome. Int J Obes (Lond) 2016; 40:346-355.
70. Garcia-Gonzalez MA, Carette C, Bagattin A, et al. A suppressor locus for MODY3-diabetes. Sci Rep 2016; 6:33087.
71. Freeman H, Shimomura K, Horner E, et al. Nicotinamide nucleotide transhy-drogenase: a key role in insulin secretion. Cell Metab 2006; 3:35-45.
72. Freeman HC, Hugill A, Dear NT, et al. Deletion of nicotinamide nucleotide transhydrogenase: a new quantitive trait locus accounting for glucose intolerance in C57BL/6J mice. Diabetes 2006; 55:2153-2156.
73. Minokoshi Y, Kahn CR, Kahn BB. Tissue-specific ablation of the GLUT4 glucose transporter or the insulin receptor challenges assumptions about insulin action and glucose homeostasis. J Biol Chem 2003; 278:33609-33612.
74. Obici S, Zhang BB, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 2002; 8:1376-1382.
75. Konner AC, Janoschek R, Plum L, et al. Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production. Cell Metab 2007; 5:438-449.
76. Hidaka S, Yoshimatsu H, Kondou S, et al. Chronic central leptin infusion restores hyperglycemia independent of food intake and insulin level in streptozotocin-induced diabetic rats. FASEB J 2002; 16:509-518.
77. Perry RJ, Peng L, Barry NA, et al. Acetate mediates a microbiome-brain-b-cell axis to promote metabolic syndrome. Nature 2016; 534:213-217.
78. Nadeau JH, Dudley AM. Genetics. Systems genetics. Science 2011; 331:1015-1016.
79. Visscher PM. Human complex trait genetics in the 21st century. Genetics 2016; 202:377-379.